Yohimbine is a 5-HT<inf>1A</inf> agonist in rats in doses exceeding 1mg/kg.

Dmitry Zaretsky, Maria V. Zaretskaia, Joseph A. DiMicco, Daniel Rusyniak

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Yohimbine is a prototypical alpha2-adrenergic receptor antagonist. Due to its relatively high selectivity, yohimbine is often used in experiments whose purpose is to examine the role of these receptors. For example, yohimbine has been employed at doses of 1-5mg/kg to reinstate drug-seeking behavior after extinction or to antagonize general anesthesia, an effects presumably being a consequence of blocking alpha2-adrenergic receptors. In this report we characterized dose-dependent autonomic and behavioral effects of yohimbine and its interaction with an antagonist of 5-HT<inf>1A</inf> receptors, WAY 100,635. In low doses (0.5-2mg/kg i.p.) yohimbine induced locomotor activation which was accompanied by a tachycardia and mild hypertension. Increasing the dose to 3-4.5mg/kg reversed the hypertension and locomotor activation and induced profound hypothermia. The hypothermia as well as the suppression of the locomotion and the hypertension could be reversed by the blockade of 5-HT<inf>1A</inf> receptors with WAY 100635. Our data confirm that yohimbine possesses 5-HT<inf>1A</inf> properties, and demonstrated that in doses above 1mg/kg significantly activate these receptors.

Original languageEnglish
Article number31537
Pages (from-to)215-219
Number of pages5
JournalNeuroscience Letters
Volume606
DOIs
StatePublished - Oct 8 2015

Fingerprint

Serotonin 5-HT1 Receptor Agonists
Yohimbine
Receptor, Serotonin, 5-HT1A
Hypertension
Drug-Seeking Behavior
Autonomic Agents
Induced Hypothermia
Adrenergic Antagonists
Locomotion
Hypothermia
Tachycardia
General Anesthesia
Adrenergic Receptors

Keywords

  • 5-HT1A receptors
  • Body temperature
  • Locomotor activity
  • Yohimbine

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Yohimbine is a 5-HT<inf>1A</inf> agonist in rats in doses exceeding 1mg/kg. / Zaretsky, Dmitry; Zaretskaia, Maria V.; DiMicco, Joseph A.; Rusyniak, Daniel.

In: Neuroscience Letters, Vol. 606, 31537, 08.10.2015, p. 215-219.

Research output: Contribution to journalArticle

@article{9f167db1569240f79311e69dfe7d7133,
title = "Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1mg/kg.",
abstract = "Yohimbine is a prototypical alpha2-adrenergic receptor antagonist. Due to its relatively high selectivity, yohimbine is often used in experiments whose purpose is to examine the role of these receptors. For example, yohimbine has been employed at doses of 1-5mg/kg to reinstate drug-seeking behavior after extinction or to antagonize general anesthesia, an effects presumably being a consequence of blocking alpha2-adrenergic receptors. In this report we characterized dose-dependent autonomic and behavioral effects of yohimbine and its interaction with an antagonist of 5-HT1A receptors, WAY 100,635. In low doses (0.5-2mg/kg i.p.) yohimbine induced locomotor activation which was accompanied by a tachycardia and mild hypertension. Increasing the dose to 3-4.5mg/kg reversed the hypertension and locomotor activation and induced profound hypothermia. The hypothermia as well as the suppression of the locomotion and the hypertension could be reversed by the blockade of 5-HT1A receptors with WAY 100635. Our data confirm that yohimbine possesses 5-HT1A properties, and demonstrated that in doses above 1mg/kg significantly activate these receptors.",
keywords = "5-HT1A receptors, Body temperature, Locomotor activity, Yohimbine",
author = "Dmitry Zaretsky and Zaretskaia, {Maria V.} and DiMicco, {Joseph A.} and Daniel Rusyniak",
year = "2015",
month = "10",
day = "8",
doi = "10.1016/j.neulet.2015.09.008",
language = "English",
volume = "606",
pages = "215--219",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1mg/kg.

AU - Zaretsky, Dmitry

AU - Zaretskaia, Maria V.

AU - DiMicco, Joseph A.

AU - Rusyniak, Daniel

PY - 2015/10/8

Y1 - 2015/10/8

N2 - Yohimbine is a prototypical alpha2-adrenergic receptor antagonist. Due to its relatively high selectivity, yohimbine is often used in experiments whose purpose is to examine the role of these receptors. For example, yohimbine has been employed at doses of 1-5mg/kg to reinstate drug-seeking behavior after extinction or to antagonize general anesthesia, an effects presumably being a consequence of blocking alpha2-adrenergic receptors. In this report we characterized dose-dependent autonomic and behavioral effects of yohimbine and its interaction with an antagonist of 5-HT1A receptors, WAY 100,635. In low doses (0.5-2mg/kg i.p.) yohimbine induced locomotor activation which was accompanied by a tachycardia and mild hypertension. Increasing the dose to 3-4.5mg/kg reversed the hypertension and locomotor activation and induced profound hypothermia. The hypothermia as well as the suppression of the locomotion and the hypertension could be reversed by the blockade of 5-HT1A receptors with WAY 100635. Our data confirm that yohimbine possesses 5-HT1A properties, and demonstrated that in doses above 1mg/kg significantly activate these receptors.

AB - Yohimbine is a prototypical alpha2-adrenergic receptor antagonist. Due to its relatively high selectivity, yohimbine is often used in experiments whose purpose is to examine the role of these receptors. For example, yohimbine has been employed at doses of 1-5mg/kg to reinstate drug-seeking behavior after extinction or to antagonize general anesthesia, an effects presumably being a consequence of blocking alpha2-adrenergic receptors. In this report we characterized dose-dependent autonomic and behavioral effects of yohimbine and its interaction with an antagonist of 5-HT1A receptors, WAY 100,635. In low doses (0.5-2mg/kg i.p.) yohimbine induced locomotor activation which was accompanied by a tachycardia and mild hypertension. Increasing the dose to 3-4.5mg/kg reversed the hypertension and locomotor activation and induced profound hypothermia. The hypothermia as well as the suppression of the locomotion and the hypertension could be reversed by the blockade of 5-HT1A receptors with WAY 100635. Our data confirm that yohimbine possesses 5-HT1A properties, and demonstrated that in doses above 1mg/kg significantly activate these receptors.

KW - 5-HT1A receptors

KW - Body temperature

KW - Locomotor activity

KW - Yohimbine

UR - http://www.scopus.com/inward/record.url?scp=84941925000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941925000&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2015.09.008

DO - 10.1016/j.neulet.2015.09.008

M3 - Article

VL - 606

SP - 215

EP - 219

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

M1 - 31537

ER -